New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2012
23:30 EDTLGF, CALL, VALE, CLF, CSTR, MCD, CLH, INTC, BRCM, CRZO, MHR, IRWD, NFLX, IBM, SWHC, TPLM, OXM, AGN, LEN, MKC, PVH, WAG, CVS, FDO, DLTR, PAYX, BBY, RIMM, FINL, CSOD, CRM, MDP, MAPP, HLJim Cramer's "Mad Money"
Jim Cramer once again reminded his "Mad Money" viewers that we're in a stock picker's market. That's why his game plan for next week's trading is all about individual companies and their earnings reports. (Monday) Cramer will be watching Lions Gate Entertainment (LGF) to see how opening weekend goes for "The Hunger Games." He said anything less than $120M in ticket sales and investors need to sell. (Tuesday) Lennar (LEN) needs to post a strong number, or all of the gains in the home-related stocks will be at risk. Cramer was bullish on both McCormick (MKC) and PVH Corp (PVH) ahead of their reports. Walgreens (WAG) is a sell according to Cramer - he would pick up CVS Caremark (CVS) instead. (Wednesday) Expectations are high for Family Dollar (FDO) and he would use any weakness in the group to buy Dollar Tree (DLTR). He remained bullish on Paychex (PAYX) with its 4% yield. He was also bullish on cloud software purveyor Red Hat (RHT), which is up 25% for the year. (Thursday) Cramer is not a buyer of Best Buy (BBY) and said using the April 25 call options would be a better play for investors looking to gamble on earnings. He had nothing good to say about Blackberry maker Research in Motion (RIMM). (Friday) Cramer said with so much great news coming from the footwear segment, he'd be a buyer of Finish Line (FINL) on any weakness. SPECULATION FRIDAY: Cramer highlighted Cornerstone OnDemand (CSOD), a stock he said has been on his radar for many weeks. He said with shares now 10% off their highs, now is the right time to consider the company. Cramer likes Cornerstone for two reasons, first as a takeover target, and second as a stand-alone company.Similar companies have been bought at 15% higher than where Cornerstone trades. Potential competition from Salesforce.com (CRM) coming into the HR space is already baked into Cornerstones stock price, Cramer says. In his "What The Heck" segment, Cramer explained why magazine publisher Meredith (MDP) has seen its shares rally 60% since last October, despite calls that print magazines are all but dead and buried. Reasons: Meredith is not a pure-play on magazines. The company has been taking market share and increasing ad revenues. And, the companyís recent dividend boost and meaningful stock buyback program. HOMEWORK: Cramer opined on Map Pharmaceuticals (MAPP), a biotech company working with Allergan (AGN) in the treatment of migraines. Cramer said that Map is likely to be volatile and he still prefers Allergan. Cramer was bullish on Oxford Industries (OXM), a retail lifestyle brand that trades at 17x earnings with a 15% growth rate. He was bearish on MagicJack (CALL), a stock that's already run up 80% so far this year. When asked about Vale (VALE), Cramer said he prefers Cliffs Natural Resources (CLF). Cramer was not a buyer of Coinstar (CSTR). Rounding up the emails, Cramer said he's a buyer of McDonald's (MCD), he likes Clean Harbors (CLH) and investors looking for semiconductor names should consider Intel (INTC) for safety or Broadcom (BRCM) for growth. NO HUDDLE OFFENSE: Cramer followed up on Carrizo Oil & Gas (CRZO) after Thursday's interview with the company's CEO. Cramer reiterated that he thinks the stock is a buy at $30, especially given that the company's Eagle Ford assets alone are worth more than that figure. LIGHTNING ROUND: (Bullish) MHR; IRWD; NFLX; IBM. (Bearish) SWHC; TPLM; HL. Reference Link
News For LGF;LEN;MKC;PVH;WAG;CVS;FDO;DLTR;PAYX;BBY;RIMM;FINL;CSOD;CRM;MDP;MAPP;AGN;OXM;CALL;VALE;CLF;CSTR;MCD;CLH;INTC;BRCM;CRZO;MHR;IRWD;NFLX;IBM;SWHC;TPLM;HL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>
October 7, 2014
07:48 EDTIBMU.S. Chamber of Commerce to hold a discussion
Subscribe for More Information
07:12 EDTAGNAllergan requests Ackman be hindered from voting at meeting, Bloomberg says
In an effort to avoid an unsolicited $54B acquisition offer from Valeant Pharmaceuticals (VRX), Allergan (AGN) filed a request in a California court for a judge to hinder Bill Ackmanís Pershing Square from voting its 10% stake at the December shareholder meeting, according to Bloomberg, citing the filing. A hearing regarding Allergan's request is set to occur on October 28. Reference Link
06:29 EDTIBMIBM, Globalfoundries reignite discussions for chip division, Bloomberg says
IBM and Globalfoundries have restarted discussions for IBM to sell its unprofitable chip production division, according to Bloomberg, citing a person familiar with the matter. The source said that IBM could pay Globalfoundries more than $1B to take over the unit. Reference Link
06:19 EDTMCDMcDonald's Japan now sees FY loss of Y17B
McDonald's Japan is forecasting a loss for the full year of Y17B vs. its previous guidance for a Y6B profit, the Financial Times reports. The company, which is 50% owned by McDonald's, sees food supplier problems impacting sales by Y45B.
October 6, 2014
16:00 EDTNFLX, CLFOptions Update; October 6, 2014
iPath S&P 500 VIX Short-Term Futures up 46c to 30.08. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX HPQ C RSH CLF PBR according to Track Data.
12:54 EDTVALE, CLFMining stocks rise after report of potential Rio Tinto, Glencore merger planning
Subscribe for More Information
12:08 EDTCLFCliffs Natural, Freeport mover higher after Bloomberg report on Rio Tinto
Subscribe for More Information
11:15 EDTAGNDurata surges after Actavis takeover
Shares of Durata Therapeutics (DRTX) are surging after the drugmaker agreed to be acquired by its larger industry peer, Actavis (ACT). WHAT'S NEW: Actavis announced it will commence a tender offer to acquire all of the outstanding shares of Durata common stock for $23.00 per share in cash, or approximately $675M in the aggregate, and contingent value rights entitling the holder to receive additional cash payments of up to $5.00 per share if certain regulatory or commercial milestones related to Durata's lead product Dalvance are achieved. If Dalvance is approved in Europe for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI, holders of the CVR will receive $1.00 per share. If Dalvance is approved for single dose administration by the FDA, holders of the CVR will receive $1.00 per share. If a net global Dalvance revenue threshold is met over a designated time period, holders of the CVR will receive $3.00 per share. Actavis expects the acquisition to be accretive by the end of the first year, it stated. WHAT'S NOTABLE: The acquisition comes after Durata Therapeutics was granted a Special Protocol Agreement by the FDA for its Phase 3 study of Dalvance on October 3. The study was designed to study Dalvance for the treatment of patients with community-acquired pneumonia and pediatric osteomyelitis. ANALYST REACTION: BMO Capital views the acquisition as a "good deal" for Actavis that is in line with CEO Brent Saunders' goal of making investments that complement its existing business. BMO believes the acquisition does not extend Actavis' balance sheet too far, and therefore does not prevent the company from doing additional deals. The firm expects there could be more deal-related news ahead for Actavis. The Fly notes Bloomberg reported on October 2 that Salix Pharmaceuticals (SLXP) was discussing selling itself to Actavis after failing to reach a deal with Allergan (AGN). PRICE ACTION: During morning trading, Durata Therapeutics gained $9.93, or 71.5%, to $23.81, Actavis slipped $1.95, or 0.8% to $244.12, and Salix fell $4.02, or 2.6%, to $148.85.
11:00 EDTWAGOptions with decreasing implied volatilit
Subscribe for More Information
10:04 EDTMCDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abercrombie & Fitch (ANF) downgraded to Neutral from Overweight at Piper Jaffray... Air France-KLM (AFLYY) downgraded to Neutral from Buy at Citigroup... BAE Systems (BAESY) downgraded to Hold from Buy at Societe Generale... Buffalo Wild Wings (BWLD) downgraded to Neutral from Outperform at Wedbush... Church & Dwight (CHD) downgraded to Underweight from Equal Weight at Barclays... Colgate-Palmolive (CL) downgraded to Equal Weight from Overweight at Barclays... Deckers Outdoor (DECK) downgraded to Neutral from Overweight at Piper Jaffray... Delhaize (DEG) downgraded to Hold from Buy at Deutsche Bank... Fortinet (FTNT) downgraded to Equal Weight from Overweight at Morgan Stanley... McDonald's (MCD) downgraded to Equal Weight from Overweight at Morgan Stanley... Midcoast Energy (MEP) downgraded to Neutral from Buy at UBS... Mobileye (MBLY) downgraded to Market Perform from Outperform at Raymond James... Myers Industries (MYE) downgraded to Neutral from Buy at CL King... Nationstar (NSM) downgraded to Underperform from Market Perform at Keefe Bruyette... PTC Therapeutics (PTCT) downgraded to Market Perform at Cowen... PetSmart (PETM) downgraded to Equal Weight from Overweight at Barclays... Qlik Technologies (QLIK) downgraded to Equal Weight from Overweight at Morgan Stanley... Subsea 7 (SUBCY) downgraded to Neutral from Outperform at Exane BNP Paribas... Tekmira (TKMR) downgraded to Market Perform from Outperform at ... XL Group (XL) downgraded to Market Perform from Outperform at FBR Capital... Xoom (XOOM) downgraded to Underweight from Equal-Weight at Evercore.
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:36 EDTINTCSeagate, Intel invest in hybrid storage company Reduxio
Hybrid storage start-up Reduxio Systems announced that it has closed a $15M Series B funding, led by Seagate Technology (STX) and joined by existing investors Jerusalem Venture Partners, Carmel Ventures and Intel Capital (INTC). In conjunction with this investment, Seagate will obtain a seat on the Reduxio Board of Directors, the company stated.
08:10 EDTIBMArrow Electronics says now authorized distributor of Lenovo enterprise products
Arrow Electronics (RW) announced it is now an authorized North American Lenovo distributor System X and related solutions following the transition of IBMís (IBM) System X server business to Lenovo (LNVGY) effective Oct. 1. Additionally, Lenovoís ThinkServer rack servers, tower servers and enterprise storage product lines are available through Arrow. Future offerings from Lenovo through Arrow will include the low-end storage and associated networking products to be announced in the coming weeks.
08:07 EDTAGNSalix slips in pre-market trade after Actavis strikes deal for Durata
Note that Bloomberg reported on October 2, citing people with knowledge of the matter, that Salix Pharmaceuticals (SLXP) was discussing selling itself to Actavis (ACT) after failing to reach a deal with Allergan (AGN). Actavis announced this morning that it has reached a deal to acquire Durata Therapeutics (DRTX) for $675M, or $23.00 per share. In pre-market trading, shares of Salix are down nearly 2% to $150 per share.
07:13 EDTBBYMobile Marketing & Technology Magazine to hold a conference
Mobile Payments Conference is being held in Chicago on October 6-8.
07:09 EDTMCDMcDonald's downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
07:01 EDTAGNAllergan Q3 results likely to beat expectations, says Bernstein
Bernstein predicts that Allergan's Q3 EPS will exceed expectations by 15c, driven by cost cutting.
06:23 EDTINTCIntel to push Broadwell into three notebook segments, DigiTimes reports
Intel is looking to push its 14nm Broadwell processors into three major notebook segments, reports DigiTimes. According to sources from the upstream supply chain, Intel is looking to push Brodawell into the entry-level non-touchscreen traditional notebooks, 2-in-1 devices, and 14- to -17-inch performance-level notebooks. Reference Link
06:19 EDTIBMHP facing competition from Lenovo in PCs, servers, WSJ reports
Subscribe for More Information
05:49 EDTCLFStocks with implied volatility movement; MNKD CLF
Stocks with implied volatility movement; MannKind (MNKD) 71, Cliffs Natural (CLF) 99 according to iVolatility.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use